Ljubljana: A little over a year after it entered into force, the regulation meant to let a patient’s medical records follow them across Europe is revealing the distance between legal ambition and clinical reality. The European Health Data Space took effect in the spring of last year, promising a continent where an ePrescription written in one country could be dispensed in another and where a traveller falling ill abroad would not be treated by doctors working blind. Twelve months on, the framework exists, but the plumbing that would make it real is still largely unbuilt.
The timetable is deliberately gradual, which is both prudent and a source of frustration. The Commission must adopt a series of implementing acts, the detailed technical rules that turn principle into practice, by March 2027. Only after that does the regulation begin to bite. The exchange of a first group of priority data, patient summaries and electronic prescriptions, is due to become operational across all member states in 2029, with a second wave covering medical images, laboratory results and hospital discharge reports following around 2031. For patients hoping for seamless cross-border care, the promised land sits several years over the horizon.
Beneath the headline dates runs a quieter race against nearer deadlines. Health systems and the makers of electronic health record software face requirements to certify their systems for interoperability and security, a painstaking process that exposes how unevenly digitised European medicine remains. A joint action involving 29 countries is running until the end of this year to assemble the governance frameworks and shared infrastructure that national authorities will need, an acknowledgement that many member states cannot yet meet the regulation’s demands on their own. Some countries arrive with mature digital health systems and a population accustomed to electronic records, while others are still wrestling paper and incompatible local databases into shape.
The unevenness is the central worry. The cross-border platform that the data space is meant to supercharge already connects a number of countries for at least one service, but coverage is patchy and the functions on offer fall well short of the full vision. A regulation that applies uniformly across a union of starkly different starting points risks delivering its benefits first to citizens of the already-advanced systems, while patients elsewhere wait for their national infrastructure to catch up. The promise of equal access to seamless care could, in the early years, prove conspicuously unequal.
Privacy hangs over the entire project. Pooling sensitive medical information and allowing its reuse for research and policy, however carefully governed, makes some patients and advocacy groups uneasy, and the rules on consent, opt-outs and the secondary use of data have been among the most contested elements of the whole regulation. Officials insist the safeguards are robust and that the gains, faster diagnosis, fewer duplicated tests, better-informed treatment, justify the architecture. Sceptics counter that trust, once lost in a data breach or a misuse scandal, would be far harder to rebuild than any technical system.
For now the European Health Data Space is a structure of deadlines and intentions more than a working service. Its first anniversary is less a celebration than a status check, and the verdict is mixed. The law is in place, the direction is set, and the hardest work, persuading 27 health systems to speak the same digital language, is only just beginning.
